Literature DB >> 30590569

Saturated Fat Ingestion Promotes Lipopolysaccharide-Mediated Inflammation and Insulin Resistance in Polycystic Ovary Syndrome.

Frank González1, Robert V Considine2, Ola A Abdelhadi3, Anthony J Acton2.   

Abstract

Context: Inflammation and insulin resistance (IR) are often present in polycystic ovary syndrome (PCOS). Objective: We determined the effect of saturated fat ingestion on circulating lipopolysaccharide (LPS) and mononuclear cell (MNC) toll-like receptor-4 (TLR-4) and suppressor of cytokine signaling-3 (SOCS-3) in women with PCOS. Design: Cross-sectional study. Setting: Academic medical center. Patients: Nineteen reproductive-age women with PCOS (10 lean, 9 obese) and 19 ovulatory control subjects (10 lean, 9 obese). Main Outcome Measures: LPS and TNFα levels were measured in plasma. TLR-4 and SOCS-3 mRNA and protein content were quantified in MNC from blood collected after fasting and 2, 3, and 5 hours after saturated fat ingestion. Insulin sensitivity was derived from an oral glucose tolerance test (ISOGTT). Androgen secretion was assessed from blood collected after fasting and 24, 48, and 72 hours after human chorionic gonadotropin (HCG) administration.
Results: Regardless of PCOS status, subjects who were obese had lipid-induced increases in circulating LPS and TLR-4 protein content compared with subjects who were lean. Lean and obese women with PCOS had lipid-induced increases in plasma TNFα and SOCS-3 mRNA and protein content compared with lean control subjects. Both PCOS groups had lower ISOGTT and greater HCG-stimulated androgen secretion compared with control subjects. The LPS and SOCS-3 responses were negatively correlated with ISOGTT and positively correlated with HCG-stimulated androgen secretion.
Conclusion: In PCOS, lipid-induced LPS-mediated inflammation through TLR-4 is associated with obesity and worsened by PCOS, whereas lipid-induced increases in SOCS-3 may represent an obesity-independent, TNFα-mediated mechanism of IR.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30590569      PMCID: PMC6364509          DOI: 10.1210/jc.2018-01143

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  48 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling.

Authors:  Anne Corbould; Young-Bum Kim; Jack F Youngren; Celia Pender; Barbara B Kahn; Anna Lee; Andrea Dunaif
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-12-21       Impact factor: 4.310

3.  Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.

Authors:  X H Xu; P K Shah; E Faure; O Equils; L Thomas; M C Fishbein; D Luthringer; X P Xu; T B Rajavashisth; J Yano; S Kaul; M Arditi
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

4.  The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome 'at-risk' population.

Authors:  F Fava; R Gitau; B A Griffin; G R Gibson; K M Tuohy; J A Lovegrove
Journal:  Int J Obes (Lond)       Date:  2012-03-13       Impact factor: 5.095

5.  Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome.

Authors:  L H Zhang; H Rodriguez; S Ohno; W L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

6.  Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome.

Authors:  Frank González; John P Kirwan; Neal S Rote; Judi Minium
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-18       Impact factor: 4.310

7.  Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters.

Authors:  K R Feingold; I Hardardottir; R Memon; E J Krul; A H Moser; J M Taylor; C Grunfeld
Journal:  J Lipid Res       Date:  1993-12       Impact factor: 5.922

8.  Inflammation in response to glucose ingestion is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome.

Authors:  Frank González; Chang Ling Sia; Marguerite K Shepard; Neal S Rote; Judi Minium
Journal:  J Clin Endocrinol Metab       Date:  2012-08-17       Impact factor: 5.958

9.  Microbiota and SCFA in lean and overweight healthy subjects.

Authors:  Andreas Schwiertz; David Taras; Klaus Schäfer; Silvia Beijer; Nicolaas A Bos; Christiane Donus; Philip D Hardt
Journal:  Obesity (Silver Spring)       Date:  2009-06-04       Impact factor: 5.002

10.  In vitro evidence that hyperglycemia stimulates tumor necrosis factor-alpha release in obese women with polycystic ovary syndrome.

Authors:  F González; N S Rote; J Minium; J P Kirwan
Journal:  J Endocrinol       Date:  2006-03       Impact factor: 4.286

View more
  20 in total

1.  Lipid-induced mononuclear cell cytokine secretion in the development of metabolic aberration and androgen excess in polycystic ovary syndrome.

Authors:  F González; R V Considine; O A Abdelhadi; A J Acton
Journal:  Hum Reprod       Date:  2020-05-01       Impact factor: 6.918

2.  Oxidative Stress in Response to Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome.

Authors:  Frank González; Robert V Considine; Ola A Abdelhadi; Anthony J Acton
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

3.  Current concepts of polycystic ovary syndrome pathogenesis.

Authors:  Robert L Rosenfield
Journal:  Curr Opin Pediatr       Date:  2020-10       Impact factor: 2.856

4.  Saturated fat ingestion stimulates proatherogenic inflammation in polycystic ovary syndrome.

Authors:  Frank González; Robert V Considine; Ola A Abdelhadi; Jiaping Xue; Anthony J Acton
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-10-11       Impact factor: 4.310

5.  An update of polycystic ovary syndrome: causes and therapeutics options.

Authors:  Abeer M Rababa'h; Bayan R Matani; Alaa Yehya
Journal:  Heliyon       Date:  2022-10-10

6.  Inflammation Triggered by Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome.

Authors:  Frank González; Robert V Considine; Ola A Abdelhadi; Anthony J Acton
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

7.  Saturated Fat Ingestion Promotes Lipopolysaccharide-Mediated Inflammation and Insulin Resistance in Polycystic Ovary Syndrome.

Authors:  Frank González; Robert V Considine; Ola A Abdelhadi; Anthony J Acton
Journal:  J Clin Endocrinol Metab       Date:  2019-03-01       Impact factor: 5.958

8.  TLR2 and TLR4 Surface and Gene Expression in White Blood Cells after Fasting and Oral Glucose, Lipid and Protein Challenges: Influence of Obesity and Sex Hormones.

Authors:  M Ángeles Martínez-García; Miriam Ojeda-Ojeda; Eulalia Rodríguez-Martín; María Insenser; Samuel Moncayo; Francisco Álvarez-Blasco; Manuel Luque-Ramírez; Héctor F Escobar-Morreale
Journal:  Biomolecules       Date:  2020-01-09

9.  Dietary α-Linolenic Acid-Rich Flaxseed Oil Exerts Beneficial Effects on Polycystic Ovary Syndrome Through Sex Steroid Hormones-Microbiota-Inflammation Axis in Rats.

Authors:  Ting Wang; Liping Sha; Yiwei Li; Lili Zhu; Zhen Wang; Ke Li; Haixia Lu; Ting Bao; Li Guo; Xiaoxia Zhang; Hao Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-27       Impact factor: 5.555

10.  Metabolic Cytokines at Fasting and During Macronutrient Challenges: Influence of Obesity, Female Androgen Excess and Sex.

Authors:  M Ángeles Martínez-García; Samuel Moncayo; María Insenser; Francisco Álvarez-Blasco; Manuel Luque-Ramírez; Héctor F Escobar-Morreale
Journal:  Nutrients       Date:  2019-10-24       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.